Evidence map›Paper›PMID 26150532›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

The B Cell-Stimulatory Cytokines BLyS and APRIL Are Elevated in Human Periodontitis and Are Required for B Cell-Dependent Bone Loss in Experimental Murine Periodontitis.

Toshiharu Abe, Mohammed AlSarhan, Manjunatha R Benakanakere, Tomoki Maekawa, Denis F Kinane, Michael P Cancro, Jonathan M Korostoff, George Hajishengallis

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Toshiharu AbeDepartment of Microbiology, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104;
Mohammed AlSarhanDepartment of Periodontics, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104; and.
Manjunatha R BenakanakereDepartment of Periodontics, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104; and.
Tomoki MaekawaDepartment of Microbiology, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104;
Denis F KinaneDepartment of Periodontics, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104; and.
Michael P CancroDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Jonathan M KorostoffDepartment of Periodontics, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104; and geoh@upenn.edu jkorosto@upenn.edu.
George HajishengallisDepartment of Microbiology, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104; geoh@upenn.edu jkorosto@upenn.edu.ORCID http://orcid.org/0000-0001-7392-8852
University of Pennsylvania · US

Funding

Role of complement in kidney disorders: from hemodialysis to transportationP01AI068730 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2018
$16.0M
P. gingivalis as a keystone pathogenR01DE015254 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2004 to 2018
$4.6M
Oral Immunity and Adjuvant ReceptorsR01DE017138 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2006 to 2014
$3.8M
Del-1: Molecular and Cellular Targets in PeriodontitisR01DE024716 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2015 to 2019
$2.0M
Epigenetics, dysbiosis and inflammation in epithelial cellsR01DE024160 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI GRAVES, DANA T · 2015 to 2019
$2.0M
Novel mechanisms and 'complement-ary' therapy in periodontitisR01DE021685 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2012 to 2016
$2.0M
ROLE OF BLYS IN PERIPHERAL B CELL SELECTION AND SURVIVALR01AI054488 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CANCRO, MICHAEL PAUL · 2004 to 2008
$1.9M
Role of IL-37 Genetic Variants in Modulating Innate Immune Resp to Periodontal PaR01DE023836 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARROS, SILVANA PEREIRA · 2014 to 2018
$1.9M
NIAID NIH HHS AI068730NIAID NIH HHS P01 AI068730NIAID NIH HHS R01 AI054488NIDCR NIH HHS DE015254NIDCR NIH HHS DE017138NIDCR NIH HHS DE021685NIDCR NIH HHS DE023836NIDCR NIH HHS DE024716NIDCR NIH HHS R01 DE015254NIDCR NIH HHS R01 DE017138NIDCR NIH HHS R01 DE021685NIDCR NIH HHS R01 DE023836NIDCR NIH HHS R01 DE024160NIDCR NIH HHS R01 DE024716
6 · The paper itself

Abstract

B-lineage cells (B lymphocytes and plasma cells) predominate in the inflammatory infiltrate of human chronic periodontitis. However, their role in disease pathogenesis and the factors responsible for their persistence in chronic lesions are poorly understood. In this regard, two cytokines of the TNF ligand superfamily, a proliferation-inducing ligand (APRIL) and B-lymphocyte stimulator (BLyS), are important for the survival, proliferation, and maturation of B cells. Thus, we hypothesized that APRIL and/or BLyS are upregulated in periodontitis and contribute to induction of periodontal bone loss. This hypothesis was addressed in both human and mouse experimental systems. We show that, relative to healthy controls, the expression of APRIL and BLyS mRNA and protein was upregulated in natural and experimental periodontitis in humans and mice, respectively. The elevated expression of these cytokines correlated with increased numbers of B cells/plasma cells in both species. Moreover, APRIL and BLyS partially colocalized with κ L chain-expressing B-lineage cells at the epithelial-connective tissue interface. Ligature-induced periodontitis resulted in significantly less bone loss in B cell-deficient mice compared with wild-type controls. Ab-mediated neutralization of APRIL or BLyS diminished the number of B cells in the gingival tissue and inhibited bone loss in wild-type, but not in B cell-deficient, mice. In conclusion, B cells and specific cytokines involved in their growth and differentiation contribute to periodontal bone loss. Moreover, APRIL and BLyS have been identified as potential therapeutic targets in periodontitis.

Indexed as

AdultAgedAlveolar Bone LossAnimalsB-Cell Activating FactorB-LymphocytesCase-Control StudiesDisease Models, AnimalFemaleGene ExpressionHumansImmunoglobulin kappa-ChainsMaleMiceMice, KnockoutMiddle AgedB-Cell Activating FactorImmunoglobulin kappa-ChainsRNA, MessengerTumor Necrosis Factor Ligand Superfamily Member 13

Identifiers

PMID26150532
PMCPMC4530049
OpenAlexW2110508835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.